Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,358 JPY | +0.28% | +0.35% | +20.21% |
Apr. 09 | H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy | MT |
Mar. 29 | Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation | MT |
Business Summary
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
Number of employees: 34,388
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
67.6
%
| 1,137,857 | 65.5 % | 1,364,358 | 67.6 % | +19.91% |
Nutraceuticals
23.9
%
| 437,014 | 25.1 % | 483,325 | 23.9 % | +10.60% |
Others
6.6
%
| 127,271 | 7.3 % | 133,818 | 6.6 % | +5.14% |
Consumer Products
1.8
%
| 35,854 | 2.1 % | 37,066 | 1.8 % | +3.38% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
42.2
%
| 664,607 | 38.2 % | 851,355 | 42.2 % | +28.10% |
Japan
33.2
%
| 654,662 | 37.7 % | 670,850 | 33.2 % | +2.47% |
Others
12.7
%
| 226,622 | 13.0 % | 255,673 | 12.7 % | +12.82% |
Europe
10.8
%
| 173,207 | 10.0 % | 218,667 | 10.8 % | +26.25% |
North America
1.1
%
| 18,897 | 1.1 % | 22,021 | 1.1 % | +16.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08-07-07 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 15-02-28 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-07 |
Masanori Udagawa
CTO | Chief Tech/Sci/R&D Officer | - | - |
Makoto Inoue
COO | Chief Operating Officer | 65 | 20-03-26 |
Shuichi Takagi
BRD | Director/Board Member | 58 | 18-12-31 |
Yoshiro Matsuo
BRD | Director/Board Member | 63 | 08-07-07 |
Noriko Tojo
BRD | Director/Board Member | 60 | 08-08-19 |
Toshifumi Arai
IRO | Public Communications Contact | - | - |
Yuji Kogure
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08-07-07 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-07 |
Director/Board Member | 57 | 17-03-29 | |
Yoshiro Matsuo
BRD | Director/Board Member | 63 | 08-07-07 |
Makoto Inoue
COO | Chief Operating Officer | 65 | 20-03-26 |
Yukio Matsutani
BRD | Director/Board Member | 74 | 16-02-29 |
Shuichi Takagi
BRD | Director/Board Member | 58 | 18-12-31 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 15-02-28 |
Mayo Mita
BRD | Director/Board Member | 63 | 20-02-29 |
Tatsuaki Kitachi
BRD | Director/Board Member | 68 | 22-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 557,835,617 | 454,156,297 ( 81.41 %) | 15,149,580 ( 2.716 %) | 81.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
15,149,500 | 2.72% | 631,625,377 $ | |
382,994,120 | 20.88% | 321,508,244 $ | |
DAIICHI SANKYO CO., LTD. 0.33% | 6,406,200 | 0.33% | 202,203,055 $ |
EARTH CORPORATION 23.25% | 5,148,000 | 23.25% | 146,774,731 $ |
NICHIBAN CO., LTD. 32.59% | 6,758,000 | 32.59% | 88,591,433 $ |
THE AWA BANK, LTD. 6.13% | 2,517,000 | 6.13% | 45,784,809 $ |
350,788 | 5.53% | 30,746,877 $ | |
DONG-A ST CO., LTD. 6.30% | 542,382 | 6.30% | 29,853,671 $ |
TBS HOLDINGS,INC. 0.59% | 1,000,000 | 0.59% | 28,801,740 $ |
EIKEN CHEMICAL CO., LTD. 3.75% | 1,500,000 | 3.75% | 19,822,260 $ |
Company contact information
Otsuka Holdings Co., Ltd.
Shinagawa Grand Central Tower, 12/F 2-16-4 Konan
108-8241, Tokyo
+
http://www.otsuka.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.21% | 22.23B | |
+18.44% | 42.77B | |
+13.23% | 14.44B | |
+12.17% | 13.05B | |
+35.95% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 4.97B | |
-6.46% | 4.6B |
- Stock Market
- Equities
- 4578 Stock
- Company Otsuka Holdings Co., Ltd.